Theragen EtexLtd Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Theragen EtexLtd.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	38.2%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Lacklustre Performance Is Driving Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) Low P/E

Oct 17

We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings

Nov 23

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Theragen EtexLtd yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KOSDAQ:A066700 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (KRW Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	241,946	27,401	-874	8,039	N/A
3/31/2024	231,954	27,487	4,728	13,130	N/A
12/31/2023	221,725	27,774	6,509	12,125	N/A
9/30/2023	209,604	4,817	8,206	10,469	N/A
6/30/2023	201,858	5,597	6,593	11,910	N/A
3/31/2023	193,983	7,248	6,984	12,716	N/A
12/31/2022	190,769	11,038	3,064	9,593	N/A
9/30/2022	186,888	7,854	7,123	13,088	N/A
6/30/2022	181,746	-1,429	6,813	11,676	N/A
3/31/2022	176,380	-5,700	-1,142	3,121	N/A
12/31/2021	166,567	-11,854	167	4,007	N/A
9/30/2021	158,350	-9,012	-1,822	1,999	N/A
6/30/2021	154,033	-5,947	-340	4,057	N/A
3/31/2021	147,518	-9,595	4,368	8,916	N/A
12/31/2020	143,023	-8,968	8,240	13,227	N/A
9/30/2020	141,701	33,345	5,679	10,388	N/A
6/30/2020	137,216	34,496	-2,046	4,230	N/A
3/31/2020	140,553	44,760	1,652	7,422	N/A
12/31/2019	138,083	43,646	-5,365	38	N/A
9/30/2019	137,076	-3,218	-17,548	-11,740	N/A
6/30/2019	133,374	-6,198	-19,170	-15,189	N/A
3/31/2019	121,750	-10,334	-25,767	-20,549	N/A
12/31/2018	117,475	-10,218	-23,214	-18,575	N/A
9/30/2018	112,293	-488	-7,646	-3,775	N/A
6/30/2018	108,914	1,650	489	3,982	N/A
3/31/2018	110,585	743	N/A	5,716	N/A
12/31/2017	107,592	1,274	N/A	1,777	N/A
9/30/2017	107,268	-1,617	N/A	-3,091	N/A
6/30/2017	103,572	-154	N/A	-4,689	N/A
3/31/2017	99,384	534	N/A	-6,650	N/A
12/31/2016	101,283	2,043	N/A	-8,380	N/A
9/30/2016	97,942	-6,495	N/A	-10,345	N/A
6/30/2016	99,460	-6,824	N/A	-8,337	N/A
3/31/2016	100,873	-6,550	N/A	-7,550	N/A
12/31/2015	98,884	-6,803	N/A	45	N/A
9/30/2015	90,006	3,665	N/A	1,070	N/A
6/30/2015	87,810	3,975	N/A	105	N/A
3/31/2015	86,831	1,932	N/A	1,798	N/A
12/31/2014	89,743	1,479	N/A	199	N/A
9/30/2014	98,082	723	N/A	-1,522	N/A
6/30/2014	96,558	-421	N/A	1,386	N/A
3/31/2014	96,706	1,208	N/A	-480	N/A
12/31/2013	90,731	1,327	N/A	-743	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if A066700's forecast earnings growth is above the savings rate (2.6%).

Kazançlar ve Piyasa: Insufficient data to determine if A066700's earnings are forecast to grow faster than the KR market

Yüksek Büyüme Kazançları: Insufficient data to determine if A066700's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if A066700's revenue is forecast to grow faster than the KR market.

Yüksek Büyüme Geliri: Insufficient data to determine if A066700's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if A066700's Return on Equity is forecast to be high in 3 years time

Theragen EtexLtd Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Lacklustre Performance Is Driving Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) Low P/E

New major risk - Financial data availability

Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Investor sentiment deteriorates as stock falls 18%

Cytogen, Inc. (KOSDAQ:A217330) agreed to acquire 99.88% stake in Theragen Genomecare Co. Ltd from Theragen Etex Co.,Ltd. (KOSDAQ:A066700) and Daeilgen Bio for KRW 13.2 billion.

Cytogen, Inc. (KOSDAQ:A217330) agreed to acquire 99.88% stake in Theragen Genomecare Co. Ltd from Theragen Etex Co.,Ltd. (KOSDAQ:A066700) and Daeilgen Bio for KRW 13.2 billion.

New minor risk - Market cap size

Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

New minor risk - Market cap size

New minor risk - Profit margin trend

Now 21% undervalued

Investor sentiment improves as stock rises 20%

No independent directors

No independent directors

First quarter 2021 earnings released: ₩23.00 loss per share (vs ₩3.00 loss in 1Q 2020)

Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

New 90-day low: ₩7,920

Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?

New 90-day low: ₩8,510

Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?

New 90-day low: ₩9,550

A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings

New 90-day low: ₩9,690

New 90-day high - ₩13,300

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin